U.S. Appeals Court Reinstates President Trump’s Import Tariffs
A U.S. federal appeals court has reinstated U.S. President Donald Trump’s import tariffs a day after a trade court had ruled that the duties are unlawful and ordered a halt to them.The U.S. Court of Appeals for the Federal Circuit in Washington, D.C. reinstated the tariffs while it considers the case and gives both the plaintiffs and Trump administration time to prepare their legal arguments in the matter. A surprise ruling by the U.S. Court of International Trade on May 28 had threatened to end the imposition of Trump’s “retaliatory tariffs” on most of America’s trading partners, including Canada. The halt to import tariffs also threatened to prevent President Trump from continuing to wield his favourite economic weapon.Trump has repeatedly threatened to impose huge tariffs on other nations to bring them to the bargaining table on trade or get them to do as he wants. The U.S. president most recently threatened sweeping tariffs of as high as 50% on the European Union (EU). However, Trump almost always backs down on his tariff threats. His administration initially imposed import duties of 145% on China before lowering them to 30%. The back-and-forth on tariffs has led to investors to coin a term for the current situation and its impact on the stock market, calling it the “TACO trade,” which is an acronym from “Trump always chickens out.”It is not clear where the reinstatement of Trump’s tariffs leaves the U.S. or the president’s administration. Immediately after the U.S. Court of International Trade blocked the import duties, Trump said he would take the matter to America’s Supreme Court.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


